+33,471.1%
ORCL vs PSA
+14,185.8%
+19,285.4%
-84.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.1% | -1.2% | +4.3% | +3.4% |
| 7D | +5.3% | -3.7% | +8.9% | +6.4% |
| 30D | +10.0% | -7.7% | +17.7% | +12.5% |
| 3M | -32.6% | -0.6% | -32.0% | -32.8% |
| 6M | +4.9% | -0.9% | +5.8% | +4.3% |
| YTD | -17.8% | +18.7% | -36.4% | -22.7% |
| 1Y | -28.0% | +7.6% | -35.6% | -30.6% |
| 3Y | +36.0% | +23.7% | +12.4% | +24.0% |
| 5Y | +88.7% | +13.7% | +75.1% | +74.6% |
| 10Y | +346.9% | +98.9% | +248.0% | +241.8% |
| All | +33,471.1% | +14,185.8% | +19,285.4% | +14,002.6% |
Cumulative growth
Daily Returns
Daily percentage return beside PSA.
Daily Out/Under-Performance
Portfolio return minus PSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling